Skip to main content
Premium Trial:

Request an Annual Quote

Pete Betzelos and Joachim Schorr

Fluidigm has appointed Pete Betzelos as senior vice president of marketing, and Joachim Schorr as senior vice president of research and development. They will both report to Marc Unger, executive vice president of research, development, and marketing. Betzelos most recently served as global leader of clinical next-generation sequencing in vitro diagnostics systems at Thermo Fisher Scientific. Previously, he was vice president of global marketing at Cepheid and has held executive positions at Roche. Schorr most recently served as CSO at Caris Life Sciences. Previously he served as managing director and senior vice president of global research and development at Qiagen.

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.